Comparative efficacy and safety of local and peripheral venous thrombolytic therapy with urokinase for thrombosed hemodialysis arteriovenous fistulas

Wan,Ziming; Xiang,Rui; Wang,Hui; Zhong,Qing; Tu,Bo

doi:10.3892/etm.2019.7415

Comparative efficacy and safety of local and peripheral venous thrombolytic therapy with urokinase for thrombosed hemodialysis arteriovenous fistulas

Authors:
- Ziming Wan
- Rui Xiang
- Hui Wang
- Qing Zhong
- Bo Tu
View Affiliations

Affiliations: Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China, Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China, Department of Ultrasonography, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China
Published online on: March 20, 2019 https://doi.org/10.3892/etm.2019.7415
Pages: 4279-4284

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Arteriovenous fistula (AVF) thrombosis is a common complication in patients undergoing hemodialysis, and early intervention is required. Urokinase has been used as a thrombolytic agent for declotting the thrombosed access. However, the optimal route for infusing urokinase remains to be determined. In the present retrospective observational study, 49 patients who underwent local venous infusion and 57 patients with peripheral venous infusion of urokinase were included. A urokinase dosage of 300,000 U was administered until successful thrombolysis, which was a maximum of three times. Age, sex, period of dialysis, time of AVF placement, systolic and diastolic blood pressure and thrombus age were similar between the two groups. The efficacy of urokinase infusion via the two routes in resolving thrombosed AVFs, defined as successful fibrinolysis, and the safety, defined as the number of bleeding events, was compared. The cumulative thrombolysis success rate following three sessions of thrombolytic therapy in the local venous thrombolysis group was higher compared with that in the peripheral venous thrombolysis group (85.7 vs. 68.4%; P=0.04). The local thrombolysis group exhibited less ecchymosis (4.1 vs. 14.0%; P=0.07), epistaxis (2.0 vs. 10.5%; P=0.08) and gingival bleeding (4.1 vs. 19.3%; P=0.02) events compared with the peripheral thrombolysis group. Further analyses demonstrated that systolic [odds ratio (OR)=1.10; 95% confidence interval (CI), 1.03‑1.17; P<0.01] and diastolic (OR=1.08; 95% CI, 1.02‑1.14; P<0.05) blood pressure were protective factors, whereas thrombus age (OR=0.91; 95% CI, 0.84‑0.99; P<0.05) was a risk factor for thrombolysis success among patients who underwent local thrombolytic therapy. Overall, the results suggest that local venous infusion of urokinase is superior to peripheral venous infusion for the treatment of patients with thrombosed fistulas.

View Figures

View References

1	Smits JH, van der Linden J, Blankestijn PJ and Rabelink TJ: Coagulation and haemodialysis access thrombosis. Nephrol Dial Transplant. 15:1755–1760. 2000. View Article : Google Scholar : PubMed/NCBI
2	Quencer KB and Friedman T: Declotting the thrombosed access. Tech Vasc Interv Radiol. 20:38–47. 2017. View Article : Google Scholar : PubMed/NCBI
3	MacRae JM, Dipchand C, Oliver M, Moist L, Lok C, Clark E, Hiremath S, Kappel J, Kiaii M, Luscombe R, et al: Arteriovenous access failure, stenosis, and thrombosis. Can J Kidney Health Dis. 3:20543581166691262016. View Article : Google Scholar : PubMed/NCBI
4	May RE, Himmelfarb J, Yenicesu M, Knights S, Ikizler TA, Schulman G, Hernanz-Schulman M, Shyr Y and Hakim RM: Predictive measures of vascular access thrombosis: A prospective study. Kidney Int. 52:1656–1662. 1997. View Article : Google Scholar : PubMed/NCBI
5	Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, et al: Effect of Fish Oil Supplementation and Aspirin Use on arteriovenous fistula failure in patients requiring hemodialysis: A randomized clinical trial. JAMA Intern Med. 177:184–193. 2017. View Article : Google Scholar : PubMed/NCBI
6	Mangiarotti G, Canavese C, Thea A, Segoloni GP, Stratta P, Salomone M and Vercellone A: Urokinase treatment for arteriovenous fistulae declotting in dialyzed patients. Nephron. 36:60–64. 1984. View Article : Google Scholar : PubMed/NCBI
7	Schon D and Mishler R: Salvage of occluded autologous arteriovenous fistulae. Am J Kidney Dis. 36:804–810. 2000. View Article : Google Scholar : PubMed/NCBI
8	Vogel PM, Bansal V and Marshall MW: Thrombosed hemodialysis grafts: Lyse and wait with tissue plasminogen activator or urokinase compared to mechanical thrombolysis with the arrow-trerotola percutaneous thrombolytic device. J Vasc Interv Radiol. 12:1157–1165. 2001. View Article : Google Scholar : PubMed/NCBI
9	Quencer KB and Oklu R: Hemodialysis access thrombosis. Cardiovasc Diagn Ther. 7 Suppl 3:S299–S308. 2017. View Article : Google Scholar : PubMed/NCBI
10	Vascular A ccess Work Group, . Clinical practice guidelines for vascular access. Am J Kidney Dis. 48 Suppl 1:S176–S247. 2006. View Article : Google Scholar : PubMed/NCBI
11	Schweizer J, Kirch W, Koch R, Elix H, Hellner G, Forkmann L and Graf A: Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol. 36:1336–1343. 2000. View Article : Google Scholar : PubMed/NCBI
12	Wang X, Su F, Ding J, Zhu H, Zhu X and Xing C: Salvage of an occluded radiocephalic fistula using urokinase and a tourniquet for patients undergoing hemodialysis. Int J Clin Exp Med. 11:812–817. 2018.
13	Gamal WM and Wagdy WM: Short-term follow-up of the effect of preoperative radial arterial diameter on early failure of arteriovenous fistula for hemodialysis. Ital J Vasc Endovasc. 23:144–147. 2016.
14	Sadaghianloo N, Jean-Baptiste E, Gaid H, Islam MS, Robino C, Declemy S, Dardik A and Hassen-Khodja R: Early surgical thrombectomy improves salvage of thrombosed vascular accesses. J Vasc Surg. 59:1377–1384 e1-2. 2014. View Article : Google Scholar : PubMed/NCBI
15	Lipari G, Tessitore N, Poli A, Bedogna V, Impedovo A, Lupo A and Baggio E: Outcomes of surgical revision of stenosed and thrombosed forearm arteriovenous fistulae for haemodialysis. Nephrol Dial Transplant. 22:2605–2612. 2007. View Article : Google Scholar : PubMed/NCBI
16	Ponikvar R: Surgical salvage of thrombosed native arteriovenous fistulas for hemodialysis by interventional nephrologists. Ther Apher Dial. 13:340–344. 2009. View Article : Google Scholar : PubMed/NCBI
17	Ponikvar R, Premru V and Kersnic B: Surgical thrombectomy of thrombosed arteriovenous grafts by interventional nephrologists. Ther Apher Dial. 15:306–310. 2011. View Article : Google Scholar : PubMed/NCBI
18	Turmel-Rodrigues L, Pengloan J, Baudin S, Testou D, Abaza M, Dahdah G, Mouton A and Blanchard D: Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol Dial Transplant. 15:2029–2036. 2000. View Article : Google Scholar : PubMed/NCBI
19	Schon D and Mishler R: Pharmacomechanical thrombolysis of natural vein fistulas: Reduced dose of TPA and long-term follow-up. Semin Dial. 16:272–275. 2003. View Article : Google Scholar : PubMed/NCBI
20	Koraen-Smith L, Krasun M, Bottai M, Hedin U, Wahlgren CM and Gillgren P: Haemodialysis access thrombosis: Outcomes after surgical thrombectomy versus catheter-directed thrombolytic infusion. J Vasc Access. 19:535–541. 2018. View Article : Google Scholar : PubMed/NCBI
21	Sadjadi SA and Sharif-Hassanabadi M: Fatal pulmonary embolism after hemodialysis vascular access declotting. Am J Case Rep. 15:172–175. 2014. View Article : Google Scholar : PubMed/NCBI
22	Wu S, Ahmad I, Qayyum S, Wicky S and Kalva SP: Paradoxical embolism after declotting of hemodialysis fistulae/grafts in patients with patent foramen ovale. Clin J Am Soc Nephrol. 6:1333–1336. 2011. View Article : Google Scholar : PubMed/NCBI
23	Pinard EA, Fazal S and Schussler JM: Catastrophic paradoxical embolus after hemodialysis access thrombectomy in a patient with a patent foramen ovale. Int Urol Nephrol. 45:1215–1217. 2013. View Article : Google Scholar : PubMed/NCBI
24	Weng FL and Berns JS: Complications of percutaneous treatment of thrombosed hemodialysis access grafts. Semin Dial. 16:257–262. 2003.PubMed/NCBI
25	Kim DH, Goo DE, Yang SB, Moon C and Choi DL: Endovascular management of immediate procedure-related complications of failed hemodialysis access recanalization. Korean J Radiol. 6:185–195. 2005. View Article : Google Scholar : PubMed/NCBI
26	Kim HK, Kwon TW, Cho YP and Moon KM: Outcomes of salvage procedures for occluded autogenous radiocephalic arteriovenous fistula. Ther Apher Dial. 15:448–453. 2011. View Article : Google Scholar : PubMed/NCBI
27	Zaleski GX, Funaki B, Kenney S, Lorenz JM and Garofalo R: Angioplasty and bolus urokinase infusion for the restoration of function in thrombosed Brescia-Cimino dialysis fistulas. J Vasc Interv Radiol. 10:129–136. 1999. View Article : Google Scholar : PubMed/NCBI
28	Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK and Chertow GM: Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 22:1526–1533. 2011. View Article : Google Scholar : PubMed/NCBI
29	Neyra NR, Ikizler TA, May RE, Himmelfarb J, Schulman G, Shyr Y and Hakim RM: Change in access blood flow over time predicts vascular access thrombosis. Kidney Int. 54:1714–1719. 1998. View Article : Google Scholar : PubMed/NCBI